LX102-C01 / Innostellar Biotherap - LARVOL DELTA

Safety and Efficacy Study of LX102-C01 Treatment of Neovascular Age-Related Macular Degeneration (nAMD) (clinicaltrials.gov) - P=N/A | N=6 | Active, not recruiting | Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

New trial • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders • Wet Age-related Macular Degeneration